J Am Coll Surg
Dr. Julie A. Margenthaler, MD
- Medicare services, 2024
- 628
- Medicare patients, 2024
- 344
- Part D claims, 2024
- 398
- Publications
- 144
- Clinical trials
- 10
- Practice address
- One Barnes-Jewish Hospital Plaza, Saint Louis, MO 63110
- Practice phone
- Call (314) 747-3000
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Primary practice
Find Dr. Margenthaler's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Julie A. Margenthaler is a surgical oncologist in Saint Louis, Missouri
Dr. Margenthaler practices at Barnes-Jewish Hospital in Saint Louis, Missouri, part of BJC Health.
Dr. Margenthaler's NPI, 1750307054, was assigned on July 14, 2006. Dr. Margenthaler graduated from Southern Illinois University School of Medicine in 1997. Dr. Margenthaler holds Missouri license 112793.
- NPI
- 1750307054NPI Registry (opens in a new tab)
- Medicare PAC ID
- 5799726113
- NPI enumeration date
- July 14, 2006
- NPI status
- Active
- Accepts Medicare assignment
- Yes
- Practice phone
- (314) 747-3000
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Female
- Estimated age
- 55
- Medical school graduation
- 1997
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)
Dr. Julie A. Margenthaler practices at 2 locations in Saint Louis, Missouri
Dr. Margenthaler's primary practice is Barnes-Jewish Hospital, at One Barnes-Jewish Hospital Plaza, Saint Louis, MO 63110 in St. Louis City. The practice phone is (314) 747-3000. Dr. Margenthaler also practices at Barnes-Jewish Hospital, 1 Barnes Jewish Hospital Plz, Saint Louis, MO 63110.
- Barnes-Jewish HospitalPrimaryOne Barnes-Jewish Hospital Plaza, Saint Louis, MO 63110 · St. Louis CityPhone(314) 747-3000
- Barnes-Jewish Hospital1 Barnes Jewish Hospital Plz, Saint Louis, MO 63110 · Saint Louis CityPhone(314) 747-3000
Sources: NPPES NPI Registry (CMS); Dmand AI Affiliation Data; and Dmand AI Practice Data
Dr. Julie A. Margenthaler is affiliated with 6 sites of care and 1 medical group
Dr. Margenthaler's primary practice is Barnes-Jewish Hospital in Saint Louis, Missouri, part of BJC Health. Dr. Margenthaler is also affiliated with Missouri Baptist Medical Center. The medical group on file is WashU Medicine Psychiatry. Dmand AI also links Dr. Margenthaler to 3 more hospitals and 1 group practice or clinic, each named with a free account.
Sources: Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data
Dmand AI tracks the EHR system at Dr. Julie A. Margenthaler's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Margenthaler practices, 6 sites in all. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| Barnes-Jewish Hospital | Available with a free account |
| +5 more affiliated sites | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
Dmand AI maps EHR vendors, IT decision makers and buying committees across BJC Health and 6.2K+ hospitals, with verified contacts in the same login.
Dr. Julie A. Margenthaler is one of 22 surgical oncologists in Missouri
Surgical oncology is Dr. Margenthaler's primary specialty in the NPI Registry, under taxonomy code 2086X0206X. Dr. Margenthaler is licensed in Missouri.
Specialties and state licenses
- Surgical oncology, MissouriPrimary
Surgical oncologists near Dr. Margenthaler
Counts of surgical oncologists with a Dmand AI profile, by place and practice. Each opens the list.
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. Julie A. Margenthaler billed Medicare for 628 services in 2024
CMS data shows 628 Medicare services from Dr. Margenthaler across 12 procedure codes in 2024, for 344 Medicare patients. Medicare paid $110,443 for them.
Dr. Margenthaler's Medicare services by type, 2023 to 2024
- 2023
- 2024
- Office and hospital visits
- 2023: 4642024: 37719%
- Surgery
- 2023: 2462024: 2383%
- Imaging
- 2023: 02024: 13
Where Dr. Margenthaler's Medicare services took place, 2024
- In an office37760%
- In a facility25140%
Dr. Margenthaler compared with the Missouri median for surgical oncologists, 2024
- Dr. Margenthaler
- Missouri median
- Medicare services
- 628vs 1444.4 times
- Medicare patients
- 344vs 1093.2 times
- Part D claims
- 348vs 359.9 times
Medians across 22 surgical oncologists in Missouri with Dmand AI profiles that report each measure.
Dr. Margenthaler's most billed Medicare procedure codes, 2024
CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.
Need commercial claims for Dr. Margenthaler?
Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Margenthaler and other surgical oncologists in Missouri.
Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks
Dr. Julie A. Margenthaler treated 344 Medicare patients in 2024, average age 73
CMS counts 344 Medicare patients who saw Dr. Margenthaler in 2024. The largest group is 65 to 74, with 203 patients. 75% of them have cancer, and 67% have high blood pressure. Their average risk score is 0.91, where 1.00 is the Medicare average.
Across all payers, Dmand AI patient panel data puts Dr. Margenthaler's median patient age at 65, with 99% women.
Dr. Margenthaler's Medicare patients by age, 2024
Chronic conditions among Dr. Margenthaler's Medicare patients, 2024
- Cancer75%
- High blood pressure67%
- High cholesterol67%
- Arthritis40%
- Anxiety27%
- Osteoporosis26%
- Mood disorders19%
- Depression17%
Share of Medicare patients with each condition. A patient can have several.
Dr. Margenthaler's patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 65
Patient panel by sex, all payers
- Women99%
- Men1%
Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data
Dr. Julie A. Margenthaler wrote 398 Medicare Part D claims in 2024
In 2024, Dr. Margenthaler wrote 398 Medicare Part D claims for 171 patients. 99% of them were for generic drugs. CMS names the drug for 348 of them, across 7 drugs with 11 or more claims each, at $6,683 in total drug cost. In 2023, CMS named 224 claims across 4 drugs.
Dr. Margenthaler's Part D claims by kind of drug, 2024
- Generic396 claims99%
- Brand-name and other2 claims1%
Dr. Margenthaler's most prescribed drugs by claims, 2024
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Drug classes CMS tracks in Dr. Margenthaler's Part D claims, 2024
- Opioids26%104 of 398 claims
- Antibiotics11%42 of 398 claims
Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.
Part D claims for drugs CMS names, 2023 to 2024
- 2023
- 2024
- Claims for drugs CMS names
- 2023: 2242024: 34855%
Drugs named by CMS: 7 in 2024, 4 in 2023.
Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data
Dr. Julie A. Margenthaler scored 84 out of 100 in Medicare's MIPS program for 2024
CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for Dr. Margenthaler for performance year 2024, reported as part of a group. Dr. Margenthaler accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 92 procedures of mastectomy by Dr. Margenthaler, more than 99% of the clinicians it reports for that procedure.
- Accepts Medicare assignment
- Yes
Dr. Margenthaler's MIPS scores, performance year 2024
- 84of 100Final score
- 71.6of 100Quality
- 100of 100Promoting Interoperability
- 40of 100Improvement Activities
- 76of 100Cost
Each score is out of 100. The final score weighs the categories CMS scored for this clinician.
Where Dr. Margenthaler ranks in Medicare procedure volume
- Mastectomy
- 99th percentile92 procedures
CMS ranks each clinician against every clinician it reports for the same procedure category.
Sources: Doctors and Clinicians National Downloadable File (CMS); Clinician Public Reporting: Overall MIPS Performance (CMS), 2024 data, released September 10, 2026; and Doctors and Clinicians Utilization Data (CMS)
For MedTech and pharma teams
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Dr. Julie A. Margenthaler has 144 publications on record
Dmand AI links 144 papers to Dr. Margenthaler, published from 2010 to 2025. 2020 was the busiest year, with 12. The most frequent topics are Breast Neoplasms, Mastectomy and Carcinoma, Ductal, Breast. Dr. Margenthaler has published most often in Ann Surg Oncol. Dr. Margenthaler's most frequent co-authors are Amy Elizabeth Cyr, MD, Rebecca L. Aft, MD and Imran Zoberi, MD.
Dr. Margenthaler's papers by year, 2016 to 2025
Topics Dr. Margenthaler writes about most
- Breast Neoplasms
- Mastectomy
- Carcinoma, Ductal, Breast
- Mastectomy, Segmental
- Carcinoma, Intraductal, Noninfiltrating
- Sentinel Lymph Node Biopsy
- Lymph Nodes
- Neoadjuvant Therapy
Dr. Margenthaler's most frequent co-authors
- Amy Elizabeth Cyr, MD36 shared papers
- Rebecca L. Aft, MD19 shared papers
- Imran Zoberi, MD17 shared papers
Recent publications by Dr. Margenthaler
JCO Clin Cancer Inform
See who Dr. Margenthaler researches with
Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Margenthaler works with, so you can find a warm path to the right surgical oncologists.
Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage
Dr. Julie A. Margenthaler has worked on 10 clinical trials
Dmand AI links Dr. Margenthaler to 10 clinical trials, 3 of them phase 2 studies. 5 are still active or recruiting. Conditions studied include Breast Neoplasms, Breast Diseases and Breast Carcinoma In Situ. Washington University School of Medicine sponsors the most, 10.
Clinical trials with Dr. Margenthaler by phase
- 1Early phase 1: 1 trial
- 2Phase 1: 2 trials
- 3Phase 2: 3 trials
- NonePhase 3: no trials
- NonePhase 4: no trials
Trials with no phase (devices, behavioral studies) are left out.
Conditions in Dr. Margenthaler's trials
- Breast Neoplasms
- Breast Diseases
- Breast Carcinoma In Situ
- Triple Negative Breast Neoplasms
- Carcinoma in Situ
Investigators on the most trials with Dr. Margenthaler
- Rebecca L. Aft, MD3 shared trials
- Amy Elizabeth Cyr, MD3 shared trials
- Foluso Olabisi Ademuyiwa, MD2 shared trials
Recent clinical trials with Dr. Margenthaler
A Phase 1B Clinical Trial to Evaluate the Safety and Immune Response to a Mammaglobin-A DNA Vaccine in ER+, HER2- Breast Cancer Patients Undergoing Neoadjuvant Endocrine Therapy or Chemotherapy (opens in a new tab)
Evaluation of Three Fraction Accelerated Partial Breast Irradiation as the Sole Method of Radiation Therapy for Low-risk Stage 0 and I Breast Carcinoma (opens in a new tab)
PECS Block vs. Multimodal Analgesia for Prevention of Persistent Postoperative Pain in Breast Surgery (opens in a new tab)
Randomized Clinical Trial of RANKL Inhibition With Denosumab on Mammographic Density in Premenopausal Women With Dense Breasts (TRIDENT) (opens in a new tab)
Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)
Dr. Julie A. Margenthaler received $88,116 in industry payments from 2016 to 2025
CMS Open Payments shows 104 general payments to Dr. Margenthaler from 8 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 82% of the total. Genentech, Inc. paid the most, $80,233.
General payments to Dr. Margenthaler by program year, 2016 to 2025
General payments to Dr. Margenthaler by kind, 2016 to 2025
- Speaker and faculty fees$72,13082%
- Travel and lodging$9,82011%
- Food and beverage$5,8587%
- Entertainment$2790%
- Gifts$290%
Companies that paid Dr. Margenthaler the most, 2016 to 2025
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Dr. Julie A. Margenthaler graduated from Southern Illinois University School of Medicine
Dr. Margenthaler graduated from Southern Illinois University School of Medicine in 1997.
- Medical school
Source: Dmand AI Professional Profile Data
Sources for Dr. Julie A. Margenthaler's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Affiliation DataDmand AI Practice Data |
| Primary practice, affiliations and health system | Dmand AI Affiliation DataDmand AI Org Hierarchy Data |
| Medicare services and procedure codes | Medicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab) |
| State medians for the same specialty | Dmand AI Peer Benchmarks |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab) |
| Part D prescribing | Medicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab) |
| MIPS scores, telehealth, assignment and procedure percentiles | Doctors and Clinicians National Downloadable File (CMS) (opens in a new tab)Clinician Public Reporting: Overall MIPS Performance (CMS) (opens in a new tab)Doctors and Clinicians Utilization Data (CMS) (opens in a new tab) |
| Publications, topics and co-authors | PubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Clinical trials and co-investigators | Dmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab) |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| Training, board certification and memberships | Dmand AI Professional Profile Data |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. Julie A. Margenthaler
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. Julie A. Margenthaler's NPI number?
Dr. Julie A. Margenthaler's NPI number is 1750307054. It was assigned on July 14, 2006, and it is active in the NPI Registry.
What kind of doctor is Dr. Julie A. Margenthaler?
Dr. Julie A. Margenthaler is a surgical oncologist in Saint Louis, Missouri. The primary specialty in the NPI Registry is Surgical Oncology Physician (taxonomy code 2086X0206X).
Where does Dr. Julie A. Margenthaler practice?
Dr. Margenthaler practices at One Barnes-Jewish Hospital Plaza, Saint Louis, MO 63110. Dr. Margenthaler also practices at 1 Barnes Jewish Hospital Plz, Saint Louis, MO 63110. Dr. Margenthaler's primary practice is Barnes-Jewish Hospital in Saint Louis, Missouri, part of BJC Health. Dmand AI also links Dr. Margenthaler to 3 hospitals and 1 group practice or clinic.
What is Dr. Julie A. Margenthaler's office phone number?
The practice phone on file for Dr. Margenthaler is (314) 747-3000.
What is Dr. Julie A. Margenthaler's medical license number?
Dr. Margenthaler holds Missouri license 112793.
Which hospitals is Dr. Julie A. Margenthaler affiliated with?
Dr. Margenthaler practices at Barnes-Jewish Hospital in Saint Louis, Missouri. Dr. Margenthaler is also affiliated with Missouri Baptist Medical Center. Dmand AI links Dr. Margenthaler to 3 more hospitals.
What medical group is Dr. Julie A. Margenthaler part of?
Dr. Margenthaler is linked to WashU Medicine Psychiatry.
Does Dr. Julie A. Margenthaler accept Medicare?
Yes. CMS data shows Dr. Margenthaler billed Medicare for 628 services in 2024, and Dr. Margenthaler accepts Medicare assignment.
What is Dr. Julie A. Margenthaler's MIPS score?
Dr. Margenthaler's MIPS final score for performance year 2024 is 84 out of 100, reported as part of a group.
How many Medicare patients does Dr. Julie A. Margenthaler see?
CMS counts 344 Medicare patients who saw Dr. Margenthaler in 2024, with an average age of 73.
Show 7 more questionsShow fewer questions
What services does Dr. Julie A. Margenthaler bill to Medicare?
In 2024, Dr. Margenthaler's most billed Medicare services were office visit, established patient (99213), office visit, new patient (99205) and surgery: blood and lymph system (38900).
Where did Dr. Julie A. Margenthaler go to medical school?
Dr. Margenthaler graduated from Southern Illinois University School of Medicine in 1997.
What drugs does Dr. Julie A. Margenthaler prescribe most?
In 2024 Medicare Part D data, Dr. Margenthaler's most prescribed drugs by claims were Tamoxifen Citrate, Hydrocodone-Acetaminophen and Raloxifene HCl.
Has Dr. Julie A. Margenthaler received payments from drug or device companies?
CMS Open Payments shows $88,116 in general payments to Dr. Margenthaler from 8 companies from 2016 to 2025. The largest total came from Genentech, Inc.
How long has Dr. Julie A. Margenthaler been practicing?
Dr. Margenthaler graduated from medical school in 1997, 29 years ago.
Does Dr. Julie A. Margenthaler do research?
Dmand AI links 144 publications to Dr. Margenthaler, published from 2010 to 2025. Dr. Margenthaler has worked on 10 clinical trials.
Who does Dr. Julie A. Margenthaler publish with?
Dr. Margenthaler's most frequent co-authors are Amy Elizabeth Cyr, MD (36 shared papers), Rebecca L. Aft, MD (19 shared papers) and Imran Zoberi, MD (17 shared papers).
Selling to surgical oncology practices?
See surgical oncologists in Missouri by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card